163 related articles for article (PubMed ID: 31070856)
1. Intravenous cyclosporine in treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis: A case series.
Vinay K; Kaushik A; Kumaran MS; Parsad D
Dermatol Ther; 2019 Jul; 32(4):e12957. PubMed ID: 31070856
[No Abstract] [Full Text] [Related]
2. Suprapharmacologic doses of intravenous dexamethasone followed by cyclosporine in the treatment of toxic epidermal necrolysis.
Rai R; Srinivas CR
Indian J Dermatol Venereol Leprol; 2008; 74(3):263-5. PubMed ID: 18583801
[No Abstract] [Full Text] [Related]
3. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gilbert M; Scherrer LA
Dermatol Ther; 2019 Jan; 32(1):e12758. PubMed ID: 30285308
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
6. Toxic epidermal necrolysis in a patient with psoriatic arthritis.
Pace J; Adami JZ; Mallia C; Mizzi A
Adv Exp Med Biol; 1999; 455():557-60. PubMed ID: 10599399
[No Abstract] [Full Text] [Related]
7. Cyclosporine in SJS/TEN management: a brief review.
Shokeen D
Cutis; 2016 Mar; 97(3):E17-8. PubMed ID: 27023091
[TBL] [Abstract][Full Text] [Related]
8. Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors.
Noe MH; Mostaghimi A; Rosenbach M; Shinkai K; Micheletti RG
J Invest Dermatol; 2018 Sep; 138(9):2068-2072. PubMed ID: 29559345
[No Abstract] [Full Text] [Related]
9. FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis.
Morgado-sCarrasco D; Fustà-Novell X; Iranzo P
Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):601-603. PubMed ID: 30971332
[No Abstract] [Full Text] [Related]
10. Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.
Lee HY; Fook-Chong S; Koh HY; Thirumoorthy T; Pang SM
J Am Acad Dermatol; 2017 Jan; 76(1):106-113. PubMed ID: 27717620
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
Gavigan GM; Kanigsberg ND; Ramien ML
J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
[TBL] [Abstract][Full Text] [Related]
12. New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis.
Roujeau JC; Mockenhaupt M; Guillaume JC; Revuz J
J Invest Dermatol; 2017 Oct; 137(10):2047-2049. PubMed ID: 28941473
[TBL] [Abstract][Full Text] [Related]
13. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Koh MJ; Tay YK
Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid.
Singh GK; Chatterjee M; Verma R
Indian J Dermatol Venereol Leprol; 2013; 79(5):686-92. PubMed ID: 23974585
[TBL] [Abstract][Full Text] [Related]
16. Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept.
Coulombe J; Belzile E; Duhamel A; Rault P; Buteau C; DeBruycker JJ; Bussières JF
J Cutan Med Surg; 2019; 23(5):547-550. PubMed ID: 31478770
[TBL] [Abstract][Full Text] [Related]
17. RF - Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Treatment Update.
de Quintana-Sancho A; Rubio-Lombraña M; Guergue Díaz-de-Cerio O; Barrutia-Borque A
Actas Dermosifiliogr; 2016 Apr; 107(3):247-8. PubMed ID: 26138285
[No Abstract] [Full Text] [Related]
18. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-induced toxic leukoencephalopathy in toxic epidermal necrolysis.
Kaushik A; Kumaran MS; Vinay K; Mehta S; Singh P
Int J Dermatol; 2019 Feb; 58(2):e36-e38. PubMed ID: 30456813
[No Abstract] [Full Text] [Related]
20. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
